JPRN-UMIN000015767尚未招募未知
The role of tadalafil for lower urinary tract symptoms after brachytherapy - Tadalafil after brachytherapy
Department of Urology, Shinshu University Hospital0 个研究点目标入组 200 人开始时间: 2014年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1)Past history of urethral or prostatic surgery 2)Past history of radiation therapy for pelvic organs 3)History of severe neurogenic disorder of lower urinary tract including Parkinson disease, diabetes mellitus, etc..
研究者
相似试验
尚未招募
不适用
Effect of tadarafil on lower urinary tract symptoms in patients treated with low dose rate brachytherapy for prostate cancerProstate cancerJPRN-UMIN000047981ara Medical University220
招募中
不适用
Tadalafil versus Tamsulosin for managing symptomatic benign prostate hypertrophy.CTRI/2018/03/012825niversity College of Medical Sciences University of Delhi
已完成
3 期
The assessment of effect of Tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasiaBenighn Prostatic Hypertrophia.Benign Prostatic HypertrophiaIRCT201008094541N1Guilan University of Medical Sciences132
进行中（未招募）
1 期
Effects of single dose tadalafil on sphincter function in healthy femalesrinary stress incontinence and fecal incontinenceMedDRA version: 22.0Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsEUCTR2020-005839-76-DKniversity hospital Bispebjerg and Frederiksberg, Department of Clinical Pharmacology24
已完成
不适用
Study on the effect of tadalafil on bladder blood flow in patients with lower urinary tract symptoms due to benign prostatic hyperplasiaPatients with lower urinary tract symptoms due to benign prostatic hyperplasiaJPRN-UMIN000020658Hidehiro Kakizaki22